Hester Biosciences Share Price
Hester Biosciences Share Price Today
As of 5 Jul 2026, Hester Biosciences share price is ₹2,203.50. The stock opened at ₹2,167.00, compared to its previous close of ₹2,167.00. During today's trading session, Hester Biosciences share price moved in the range of ₹2,167.00 to ₹2,295.00, with an average price of ₹2,231.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,239.30 and a high of ₹2,350.00. On the performance front, Hester Biosciences share price has increased by 37.04% over the last six months and is up 21.45% on a year-on-year basis.
Hester Biosciences Returns Calculator
Hester Biosciences Shareholder Returns
Hester Biosciences Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Hester Biosciences Financials
Income Statement · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹332.60 | ₹311.10 | ₹304.55 | ₹266.09 |
| Other Income | ₹9.68 | ₹3.92 | ₹10.64 | ₹15.15 |
| Total Revenue | ₹342.28 | ₹315.03 | ₹315.18 | ₹281.24 |
| Total Expenses | ₹275.76 | ₹279.56 | ₹287.84 | ₹245.50 |
| Profit Before Tax | ₹75.84 | ₹39.57 | ₹31.95 | ₹40.15 |
| Tax | ₹18.35 | ₹10.75 | ₹10.79 | ₹12.12 |
| Profit After Tax | ₹57.48 | ₹28.83 | ₹21.17 | ₹28.04 |
| EPS - Basic | ₹67.57 | ₹33.89 | ₹24.88 | ₹31.30 |
| EPS - Diluted | ₹67.57 | ₹33.89 | ₹24.88 | ₹31.30 |
Cash Flow · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹75.84 | ₹39.57 | ₹31.95 | ₹40.15 |
| Income before WC changes | ₹109.41 | ₹66.04 | ₹56.18 | ₹52.54 |
| Change in Assets | -₹31.40 | ₹8.34 | ₹13.06 | -₹42.13 |
| Change in Liabilities | ₹0.26 | ₹1.60 | -₹9.38 | ₹21.29 |
| Change in WC | -₹31.15 | ₹9.95 | ₹3.67 | -₹20.84 |
| Cash flow from Operations | ₹64.14 | ₹64.51 | ₹48.18 | ₹23.60 |
| Cash flow from Investing | -₹2.87 | -₹19.00 | -₹22.61 | -₹77.00 |
| Cash flow from Financing | -₹48.79 | -₹51.72 | -₹26.09 | ₹41.76 |
| Total Cash Flow | -₹2.82 | -₹6.72 | -₹0.36 | -₹11.59 |
| Cash (Start of the year) | ₹5.59 | ₹12.31 | ₹12.67 | ₹24.75 |
| Cash (End of the year) | ₹2.77 | ₹5.59 | ₹12.31 | ₹13.16 |
Balance Sheet · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹469.38 | ₹458.21 | ₹447.73 | ₹442.37 |
| Current Assets | ₹208.56 | ₹195.17 | ₹214.62 | ₹227.59 |
| Total Assets | ₹677.94 | ₹653.39 | ₹662.35 | ₹669.97 |
| Current Liabilities | ₹152.48 | ₹125.18 | ₹105.47 | ₹148.70 |
| Net Current Asset | ₹56.08 | ₹69.99 | ₹109.14 | ₹78.90 |
| Non-Current Liabilities | ₹157.67 | ₹201.55 | ₹254.00 | ₹232.72 |
| Equity Capital | ₹367.79 | ₹326.66 | ₹302.88 | ₹288.55 |
| Total Equity & Liabilities | ₹677.94 | ₹653.39 | ₹662.35 | ₹669.97 |
Income Statement · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹292.14 | ₹286.47 | ₹285.16 | ₹254.00 |
| Other Income | ₹7.64 | ₹4.76 | ₹4.26 | ₹5.32 |
| Total Revenue | ₹299.77 | ₹291.23 | ₹289.42 | ₹259.32 |
| Total Expenses | ₹237.09 | ₹249.47 | ₹252.69 | ₹215.40 |
| Profit Before Tax | ₹69.68 | ₹41.76 | ₹36.73 | ₹43.92 |
| Tax | ₹17.58 | ₹9.92 | ₹9.57 | ₹11.58 |
| Profit After Tax | ₹52.10 | ₹31.84 | ₹27.16 | ₹32.34 |
| EPS - Basic | ₹61.24 | ₹37.43 | ₹31.93 | ₹38.02 |
| EPS - Diluted | ₹61.24 | ₹37.43 | ₹31.93 | ₹38.02 |
Cash Flow · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹69.68 | ₹41.76 | ₹36.73 | ₹43.92 |
| Income before WC changes | ₹81.91 | ₹57.58 | ₹50.06 | ₹58.48 |
| Change in Assets | -₹10.86 | ₹13.04 | ₹10.16 | -₹44.32 |
| Change in Liabilities | -₹6.64 | ₹3.27 | -₹6.33 | ₹27.27 |
| Change in WC | -₹17.50 | ₹16.31 | ₹3.84 | -₹17.05 |
| Cash flow from Operations | ₹50.92 | ₹63.97 | ₹42.86 | ₹33.36 |
| Cash flow from Investing | -₹2.36 | -₹19.04 | -₹20.59 | -₹71.96 |
| Cash flow from Financing | -₹48.31 | -₹46.35 | -₹24.12 | ₹41.38 |
| Total Cash Flow | ₹0.25 | -₹1.42 | -₹1.85 | ₹2.77 |
| Cash (Start of the year) | ₹0.55 | ₹1.97 | ₹3.81 | ₹1.53 |
| Cash (End of the year) | ₹0.79 | ₹0.55 | ₹1.97 | ₹4.30 |
Balance Sheet · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹367.58 | ₹360.76 | ₹345.13 | ₹329.77 |
| Current Assets | ₹189.76 | ₹185.24 | ₹204.41 | ₹216.05 |
| Total Assets | ₹557.35 | ₹546.00 | ₹549.55 | ₹545.82 |
| Current Liabilities | ₹91.92 | ₹96.70 | ₹97.72 | ₹136.47 |
| Net Current Asset | ₹97.85 | ₹88.53 | ₹106.69 | ₹79.58 |
| Non-Current Liabilities | ₹80.25 | ₹110.21 | ₹139.11 | ₹116.96 |
| Equity Capital | ₹385.18 | ₹339.09 | ₹312.71 | ₹292.38 |
| Total Equity & Liabilities | ₹557.35 | ₹546.00 | ₹549.55 | ₹545.82 |
About Hester Biosciences
Hester Biosciences Limited is an India-based animal healthcare company. The Company is principally engaged in manufacturing poultry vaccines, large animal vaccines, and trading poultry, large animal, and petcare health products. It operates through three segments: Poultry Healthcare, Animal Healthcare, and Petcare. The Poultry Healthcare vaccines include Gumboro I, Inactivated Chick ND, Inactivated Coryza, Inactivated EDS, Inactivated FC3, Inactivated FC4, Inactivated IB, and Inactivated IBD. The Animal Healthcare vaccines include Goat Pox Vaccine, Live Brucella, PPR Vaccine - Nigerian 75/1, and PPR Vaccine - Sungri/96. Its Petcare products include Cefshot Tazo Injection, Hestacef CV, Hestacef DS, Pawfresh, Synoton, Petsglow, and Vitacoat. The Company also operates diagnostic labs for poultry and provides diagnostic kits for sero-surveillance and mastitis prevention for cattle farms. Its manufacturing facility is located at Meda Adraj Village, Mehsana District, Gujarat.
Hester Biosciences Financial Highlights
- Revenue: Hester Biosciences reported revenue of ₹342.28 crore in FY26 vs ₹315.02 crore in FY25. It showed an increase of 8.65% on a yearly basis.
- Operating Profit: Hester Biosciences reported an operating profit of ₹75.84 crore in FY26 vs ₹39.57 crore in FY25. It showed an increase of 91.66% on a year-on-year basis.
- Net Profit: Hester Biosciences reported a net profit of ₹57.48 crore in FY26 vs ₹28.83 crore in FY25. It showed an increase of 99.38% on a yearly basis.
Hester Biosciences Quarterly Result Highlights
- Hester Biosciences reported revenue of ₹97.08 crore in Mar 2026, compared with ₹78.09 crore in Dec 2025, representing an increase of 24.32% on a quarter-on-quarter (QoQ) basis.
- Hester Biosciences reported an operating profit of ₹25.09 crore in Mar 2026, compared with ₹13.52 crore in Dec 2025, representing an increase of 85.58% on a quarter-on-quarter (QoQ) basis.
- Hester Biosciences reported a profit of ₹16.55 crore in Mar 2026, compared with ₹9.31 crore in Dec 2025, reflecting an increase of 77.77% on a QoQ basis.
- The earnings per share (EPS) of Hester Biosciences stood at ₹67.57 during Mar 2026.
Similar Stocks
FAQs on Hester Biosciences Share Price
What is Hester Biosciences share price today?
Hester Biosciences share price is ₹2,203.50 as on 03 Jul, 2026, 15:29 IST.
How has the Hester Biosciences share price performed in the past?
In the last 1 year, Hester Biosciences delivered a return of 21.45%. The Hester Biosciences share price hit a high of ₹2,350.00 and low of ₹1,239.30.
How much is the Mutual Fund shareholding in Hester Biosciences shares?
The Mutual Fund Shareholding in Hester Biosciences was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Hester Biosciences shares ?
The 52-week high and low of Hester Biosciences share is ₹2,350.00 and ₹1,239.30 as of 03 Jul, 2026.
What is the market cap of Hester Biosciences?
The market capitalisation of Hester Biosciences is ₹1,853.35 Crores as on 03 Jul, 2026.
What are the stock symbols of Hester Biosciences?
The stock symbol of Hester Biosciences is HESTERBIO on the NSE, 524669 on the BSE, and the ISIN is INE782E01017.
What was yesterday's closing price of Hester Biosciences shares ?
Hester Biosciences shares closed yesterday at ₹2,167.00 on NSE & ₹2,178.65 on BSE
How to buy Hester Biosciences shares?
To buy Hester Biosciences shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Hester Biosciences shares on Holidays?
No, shares of Hester Biosciences or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Hester Biosciences shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Hester Biosciences?
The PE and PB ratio of Hester Biosciences is 19.31 and 2.98 respectively, as on 03 Jul, 2026, 15:29 IST.